The origin of cancer is damage to the mitochondria, the cell's powerhouses. This impairs energy production, forcing cells into a primitive state of uncontrolled growth. Genetic mutations are a downstream effect, not the primary cause.
In a ketogenic state, healthy cells enter a protective "bunker mode," slowing division. Cancer cells lack this evolutionary off-switch and remain exposed. This synergy makes tumors more vulnerable to chemotherapy, allowing for lower, less toxic doses with greater effect.
Rather than tracking glucose and ketones separately, the Glucose Ketone Index (GKI) combines them into a single, stable ratio. This number serves as a powerful biomarker for assessing one's metabolic and mitochondrial health, clearly defining zones of disease risk versus prevention.
Metastasis is not merely cancer cells breaking away. Research shows it is often driven by the body's own immune cells (macrophages) fusing with tumor stem cells. This creates a new hybrid cell that inherits the macrophage's ability to travel throughout the body.
Mainstream oncologists often advise against keto diets, fearing they accelerate cachexia (severe wasting). This conflates pathological wasting, where the tumor devours muscle, with therapeutic weight loss from a state of ketosis, which actually starves the tumor.
Aggressive treatments like radiation and chemotherapy induce immense metabolic stress, causing blood sugar to spike. This pushes the patient's body into a metabolic "red zone," which can create an environment that strengthens and feeds any remaining resistant tumor cells.
Wild wolves rarely get cancer, while it's the leading killer of domestic dogs. This stark difference highlights the impact of modern lifestyles—processed foods, inactivity, and chronic stress—on mitochondrial health, making dogs a compelling parallel for the metabolic theory of cancer in humans.
Experiments swapping nuclei between cancerous and healthy cells reveal that a cancer nucleus in a healthy cell's cytoplasm does not create cancer. This proves the mitochondria residing in the cytoplasm are the primary drivers of the disease, not nuclear genetic mutations.
Hyperbaric oxygen creates oxidative stress that healthy cells can manage but cancer cells with damaged mitochondria cannot. When combined with a ketogenic diet that already weakens the tumor, this therapy becomes a targeted weapon that selectively kills cancer cells while sparing healthy ones.
The "oncogenic paradox"—how diverse agents like chemicals, radiation, and viruses all cause cancer—is solved by a common mechanism. They all inflict chronic damage on the mitochondria's ability to produce energy efficiently using oxygen.
Healthy cells can efficiently use ketones for energy. Cancer cells, with their broken mitochondria, cannot. This creates a powerful therapeutic opportunity: a ketogenic state can nourish the body's healthy cells while simultaneously starving tumor cells of their required fuel.